Nanau, Radu M, et al. “Risk of Infections of Biological Therapies With Accent on Inflammatory Bowel Disease”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 17, no. 4, Oct. 2014, pp. 485-31, doi:10.18433/J3GG6D.